What are cookies?

Our site uses cookies. A cookie is a small text marker stored on your computer that enables us to track the use of our website. We use cookies to help us understand what our users' interests and preferences are to ensure the website is as user friendly as possible.

This site only uses cookies in order to provide a service to visitors. No personal data is stored in cookies and cookies are not used in order to provide advertising. Cookies are used for the following purposes:

Learn more about cookies on aboutcookies.org

If you have any concerns about the processing of your personal data by the Dementia Action Alliance, please contact the Secretariat, c/o Alzheimer's Society, 43-44 Crutched Friars, London, EC3N 2AE.

Accept and continue

Re:Cognition Health selected for 2 major clinical trials

Thursday 1 August 2013

Re:Cognition Health, based in London, has been selected as a study site for two of the leading global phase 3 trials for early/mild Alzheimer's. The clinical team was only established 2 years ago and now has leading experts in cognitive neurology, psychiatry, neuro-psychiatry, neuro-psychology, neuro-radiology, and specialist dementia nursing. The quality of the clinical team was critical in the decision to proceed by both sponsors, as well as the team's focus on a complete pathway of care from assessment and diagnosis, to ongoing therapy, psychology and care management support. Any patients with a relevant diagnosis can participate. For further information please go to www.re-cognitionhealth.com/clinical-trials.php